Potassium and Injection site warmth - a phase IV clinical study of FDA data

Summary:

We study 54,993 people who have side effects when taking Potassium. Injection site warmth is found, especially among people who are female, 50-59 old, also take Enbrel and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people take Potassium and have Injection site warmth. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2023

54,993 people reported to have side effects when taking Potassium.
Among them, 32 people (0.06%) have Injection site warmth.

What is Potassium?

Potassium has active ingredients of potassium. It is used in hypokalemia. Currently, eHealthMe is studying from 55,747 Potassium users.

What is Injection site warmth?

Injection site warmth is found to be associated with 1,139 drugs and 685 conditions by eHealthMe. Currently, we are studying 19,646 people who have Injection site warmth.

Number of Potassium and Injection site warmth reports submitted per year:

Could Potassium cause Injection site warmth?

Gender of people who have Injection site warmth when taking Potassium *:

female: 90.62 %
male: 9.38 %

Age of people who have Injection site warmth when taking Potassium *:

Common drugs people take besides Potassium *:

Common side effects people have besides Injection site warmth *:

Injection Site Erythema (redness at injection site): 21 people, 65.62%
Injection Site Pain: 16 people, 50.00%
Injection Site Swelling: 15 people, 46.88%
Injection Site Pruritus (severe itching at injection site): 12 people, 37.50%
Injection Site Induration: 8 people, 25.00%
Fatigue (feeling of tiredness): 8 people, 25.00%
Joint Pain: 6 people, 18.75%
Injection Site Reaction: 5 people, 15.62%
Rashes (redness): 5 people, 15.62%
Headache (pain in head): 5 people, 15.62%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 31.25%
Immunodeficiency Common Variable: 5 people, 15.62%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 12.50%
High Blood Cholesterol: 4 people, 12.50%
Blood Potassium Decreased: 3 people, 9.38%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 6.25%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.25%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and have Injection site warmth?

Check whether Injection site warmth is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Potassium side effects by duration, gender and age:

Potassium side effects (55,747 reports)

Injection site warmth treatments and more:

Injection site warmth (19,646 reports)

Common drugs associated with Injection site warmth:

How the study uses the data?

The study uses data from the FDA. It is based on potassium (the active ingredients of Potassium) and Potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.